VU0359595

Overview

VU0359595 (CID-53361951; ML-270) is a potent and selective pharmacological phospholipase D1 ( PLD1 ) inhibitor with an IC 50 of 3.7 nM. VU0359595 is >1700-fold selective for PLD1 over PLD2 ( IC 50 of 6.4 μM). VU0359595 can be used for the research of cancer , diabetes, neurodegenerative and inflammatory diseases.

Application

Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Fungal Infection | Products > Disease Areas > Glucose Metabolism | Products > Disease Areas > Infection | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Neurological Disease | Products > Research Areas > Metabolic Disease | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Infection | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Phospholipase | Products > Signaling Pathways > Fungal

Product Information

• Catalog No.: HY-101293
• CAS No.: 1246303-14-9
• Molecular Formula: C25H29BrN4O2
• Molecular Weight: 497.43
• Purity: 98.06%
• Storage: 4°C, sealed storage, away from moisture and light * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
• Availability: In-stock

Source

Original product source